Trex Wind-down, Inc. Stock

Equities

BPC

US8870802084

Biotechnology & Medical Research

Delayed Deutsche Boerse AG 02:23:45 2023-11-29 am EST 5-day change 1st Jan Change
0.292 EUR +4.29% Intraday chart for Trex Wind-down, Inc. -.--% -.--%
Sales 2021 887K 828K Sales 2022 83.18K 77.72K Capitalization 3.89M 3.64M
Net income 2021 -10M -9.34M Net income 2022 -19M -17.75M EV / Sales 2021 9.89 x
Net cash position 2021 14.05M 13.13M Net cash position 2022 8.75M 8.17M EV / Sales 2022 -58.4 x
P/E ratio 2021
-1.34 x
P/E ratio 2022
-0.14 x
Employees 9
Yield 2021 *
-
Yield 2022
-
Free-Float 99.37%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.28
Extreme 0.28
2.92
3 years
0.28
Extreme 0.28
51.75
5 years
0.28
Extreme 0.28
184.13
10 years
0.28
Extreme 0.28
184.13
More quotes
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.
More about the company

Quarterly revenue - Rate of surprise